EGRX
Eagle Pharmaceuticals Inc
Price:  
4.37 
USD
Volume:  
123,870.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

EGRX Relative Valuation

774.2%
Upside

As of 2024-05-22, the Relative Valuation of Eagle Pharmaceuticals Inc (EGRX) is 38.20 USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.37 USD, the upside of Eagle Pharmaceuticals Inc based on Relative Valuation is 774.2%.

The range of the Relative Valuation is 24.18 - 52.47 USD.

Range Selected
Trailing P/E multiples 26.0x - 28.7x 28.4x
Forward P/E multiples 24.5x - 27.3x 26.0x
Fair Price 24.18 - 52.47 38.20
Upside 453.3% - 1100.7% 774.2%
4.37 USD
Stock Price
38.20 USD
Fair Price

EGRX Relative Valuation - Historical P/E Data

Date P/E
2024-05-21 4.69
2024-05-20 4.95
2024-05-17 5.11
2024-05-16 5.10
2024-05-15 4.95
2024-05-14 5.01
2024-05-13 4.83
2024-05-10 4.87
2024-05-09 5.00
2024-05-08 5.10
2024-05-07 5.10
2024-05-06 4.91
2024-05-03 4.73
2024-05-02 4.72
2024-05-01 4.50
2024-04-30 4.39
2024-04-29 4.35
2024-04-26 4.47
2024-04-25 4.55
2024-04-24 4.88
2024-04-23 5.12
2024-04-22 4.88
2024-04-19 4.95
2024-04-18 4.81
2024-04-17 4.71
2024-04-16 5.03
2024-04-15 5.58
2024-04-12 4.93
2024-04-11 5.12
2024-04-10 5.05
2024-04-09 5.31
2024-04-08 5.37
2024-04-05 5.50
2024-04-04 5.59
2024-04-03 5.22
2024-04-02 4.83
2024-04-01 5.12
2024-03-28 5.63
2024-03-27 5.38
2024-03-26 5.41
2024-03-25 5.45
2024-03-22 5.42
2024-03-21 5.61
2024-03-20 6.10
2024-03-19 5.90
2024-03-18 6.03
2024-03-15 6.50
2024-03-14 6.39
2024-03-13 6.45
2024-03-12 6.15